Research output per year
Research output per year
Personal profile
Headline
PROFESSOR
Biography
Fingerprint
Dive into the research topics where Emma Guttman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Age of onset defines two distinct profiles of atopic dermatitis in adults
Facheris, P., Da Rosa, J. C., Pagan, A. D., Angelov, M., Del Duca, E., Rabinowitz, G., Gómez-Arias, P. J., Rothenberg-Lausell, C., Estrada, Y. D., Bose, S., Chowdhury, M., Shemer, A., Pavel, A. B. & Guttman-Yassky, E., Aug 2023, In: Allergy: European Journal of Allergy and Clinical Immunology. 78, 8, p. 2202-2214 13 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Alopecia areata is associated with increased genetic risk of myocardial infarction: A Mendelian randomization study
O'Hagan, R., Caldas, S. A., Correa da Rosa, J. M., Guttman-Yassky, E. & Ungar, B., 2023, (Accepted/In press) In: Journal of the European Academy of Dermatology and Venereology.Research output: Contribution to journal › Letter › peer-review
-
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
Guttman-Yassky, E., Simpson, E. L., Reich, K., Kabashima, K., Igawa, K., Suzuki, T., Mano, H., Matsui, T., Esfandiari, E. & Furue, M., 21 Jan 2023, In: The Lancet. 401, 10372, p. 204-214 11 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations -
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Mikhaylov, D., Glickman, J. W., Del Duca, E., Nia, J., Hashim, P., Singer, G. K., Posligua, A. L., Florek, A. G., Ibler, E., Hagstrom, E. L., Estrada, Y., Rangel, S. M., Colavincenzo, M., Paller, A. S. & Guttman-Yassky, E., Mar 2023, In: Archives of Dermatological Research. 315, 2, p. 181-189 9 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI
Kim, H. J., Del Duca, E., Pavel, A. B., Singer, G. K., Abittan, B. J., Chima, M. A., Kimmel, G., Bares, J., Baum, D., Gagliotti, M., Genece, J., Chu, J., Lebwohl, M. G. & Guttman-Yassky, E., Mar 2023, In: Archives of Dermatological Research. 315, 2, p. 215-221 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Press/Media
-
How to Cope With the Hidden Mental Health Effects of Eczema
7/11/23
1 item of Media coverage
Press/Media
-
Lebrikizumab Maintains Skin Clearance for 2 Years in Atopic Dermatitis
1/11/23
1 item of Media coverage
Press/Media
-
Lebrikizumab Maintains Skin Clearance for Two Years in Atopic Dermatitis
31/10/23
1 item of Media coverage
Press/Media
-
Maintenance dose of lebrikizumab may clear skin and improve symptoms in atopic dermatitis
27/10/23
1 item of Media coverage
Press/Media
-
Lebrikizumab maintenance dosing achieves dermatitis clearance up to 2 years
26/10/23
1 item of Media coverage
Press/Media